4D Molecular Therapeutics, Inc. (FDMT)
14.67
-0.24
(-1.61%)
USD |
NASDAQ |
Aug 28, 16:00
14.66
-0.01
(-0.07%)
After-Hours: 16:40
4D Molecular Therapeutics Price to Book Value : 1.987 for Aug. 28, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 27, 2026 | 2.019 |
| August 26, 2026 | 2.108 |
| August 25, 2026 | 2.129 |
| August 24, 2026 | 2.084 |
| August 21, 2026 | 2.144 |
| August 20, 2026 | 2.181 |
| August 19, 2026 | 2.27 |
| August 18, 2026 | 1.994 |
| August 17, 2026 | 1.97 |
| August 14, 2026 | 1.651 |
| August 13, 2026 | 1.578 |
| August 12, 2026 | 1.608 |
| August 11, 2026 | 1.554 |
| August 10, 2026 | 1.509 |
| August 07, 2026 | 1.456 |
| August 06, 2026 | 1.429 |
| August 05, 2026 | 1.392 |
| August 04, 2026 | 1.390 |
| August 03, 2026 | 1.367 |
| July 31, 2026 | 1.379 |
| July 30, 2026 | 1.364 |
| July 29, 2026 | 1.302 |
| July 28, 2026 | 1.334 |
| July 27, 2026 | 1.406 |
| July 24, 2026 | 1.364 |
| Date | Value |
|---|---|
| July 23, 2026 | 1.406 |
| July 22, 2026 | 1.484 |
| July 21, 2026 | 1.541 |
| July 20, 2026 | 1.502 |
| July 17, 2026 | 1.488 |
| July 16, 2026 | 1.468 |
| July 15, 2026 | 1.582 |
| July 14, 2026 | 1.585 |
| July 13, 2026 | 1.530 |
| July 10, 2026 | 1.667 |
| July 09, 2026 | 1.746 |
| July 08, 2026 | 1.764 |
| July 07, 2026 | 1.736 |
| July 06, 2026 | 1.723 |
| July 02, 2026 | 1.761 |
| July 01, 2026 | 1.719 |
| June 30, 2026 | 1.801 |
| June 29, 2026 | 1.49 |
| June 26, 2026 | 1.342 |
| June 25, 2026 | 1.333 |
| June 24, 2026 | 1.344 |
| June 23, 2026 | 1.342 |
| June 22, 2026 | 1.206 |
| June 18, 2026 | 1.118 |
| June 17, 2026 | 1.090 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Amgen, Inc. | 20.00 |
| AnaptysBio, Inc. | 127.95 |
| Precision BioSciences, Inc. | 4.552 |
| Design Therapeutics, Inc. | 4.681 |
| Inhibrx Biosciences, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 10.05 |
| Price | 14.67 |
| Earnings Yield | -18.57% |
| Market Cap | 809.99M |